trial · primary record
Adebrelimab + Chemotherapy + Radiotherapy
Small Cell Lung Cancer (SCLC)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 25 |
| Primary completion | 2028-09-01 |
| Primary endpoint | Overall Survival (OS) |
| Registry ID | NCT07909863 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:09.075Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07909863
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.